Showing 1,441 - 1,460 results of 3,189 for search '"vaccines"', query time: 0.09s Refine Results
  1. 1441
  2. 1442

    Lanskap Konteks Sosial-Sosietal dalam Pragmatik Berbasis Cybertexts Vaksinasi Covid-19 (Socio-Social Context Landscape in Cybertexts-Based Pragmatics Covid-19 Vaccination) by R. Kunjana Rahardi

    Published 2021-07-01
    “…<p>This study aims to describe the types of social-social context landscapes in cybertexts-based pragmatics related to the Covid-19 vaccination discourse. The research data is in the form of speech excerpts that contain the identity of the social-social context landscape in cybertexts. …”
    Get full text
    Article
  3. 1443

    Anti-SARS-Cov-2 S-RBD IgG Formed after BNT162b2 Vaccination Can Bind C1q and Activate Complement by Anas H. A. Abu-Humaidan, Fatima M. Ahmad, Dima Awajan, Raba’a F. Jarrar, Nader Alaridah

    Published 2022-01-01
    “…Background. The ability of vaccine-induced antibodies to bind C1q could affect pathogen neutralization. …”
    Get full text
    Article
  4. 1444
  5. 1445
  6. 1446
  7. 1447
  8. 1448
  9. 1449
  10. 1450
  11. 1451

    Assessment of Child Immunization Coverage and Associated Factors with Full Vaccination among Children Aged 12–23 Months at Mizan Aman Town, Bench Maji Zone, Southwest Ethiopia by Asrat Meleko, Mesfin Geremew, Frehiwot Birhanu

    Published 2017-01-01
    “…A total of 322 mothers/caretakers were interviewed. Based on vaccination card and mothers/caretakers’ recall, 295 (91.6%) of the children took at least a single dose of vaccine. …”
    Get full text
    Article
  12. 1452
  13. 1453

    Prevalence and Predictors of COVID-19 Vaccine Hesitancy among Health Care Workers in Tertiary Health Care Institutions in a Developing Country: A Cross-Sectional Analytical Study by Chinedu Anthony Iwu, Pius Ositadinma, Victor Chibiko, Ugochukwu Madubueze, Kenechi Uwakwe, Uche Oluoha

    Published 2022-01-01
    “…Result. The prevalence of vaccine hesitancy was 35.4%. HCWs of the Pentecostal faith (aOR: 2.52) and males (aOR: 2.72) were significantly more likely to be COVID-19 vaccine hesitant. …”
    Get full text
    Article
  14. 1454

    Development of a differentiating of infected from vaccinated animal (DIVA) ELISA to detect antibodies against Senecavirus A in pigs using two expression systems of non-structural proteins by Parin Watcharavongtip, Patumporn Jermsutjarit, Angkana Tantituvanont, Dachrit Nilubol

    Published 2025-12-01
    “…They can be valuable tools for sero-surveillance and for evaluating immunity status tests to support and approve vaccination programs for pig herds in the future.…”
    Get full text
    Article
  15. 1455
  16. 1456
  17. 1457

    Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice by Suvi Heinimäki, Maria Malm, Timo Vesikari, Vesna Blazevic

    Published 2018-01-01
    “…Norovirus (NoV) is a main cause of acute gastroenteritis across all ages worldwide. NoV vaccine candidates currently in clinical trials are based on noninfectious highly immunogenic virus-like particles (VLPs) delivered intramuscularly (IM). …”
    Get full text
    Article
  18. 1458
  19. 1459

    Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group by Laura Massaro, Annamaria Iagnocco, Florenzo Iannone, Corrado Campochiaro, Maria De Santis, Ilaria Cavazzana, Piero Ruscitti, Roberto Giacomelli, Rosario Foti, Lorenzo Dagna, Giovanna Cuomo, Giacomo De Luca, Francesco Caso, Ilenia Di Cola, Clodoveo Ferri, Vincenzo Raimondo, Francesco Ursini, Veronica Brusi, Giuseppe Varcasia, Roberta Pellegrini, Domenico Olivo, Giuseppe Murdaca, Carlo Selmi, Olga Addimanda, Erika Pigatto, Francesca Francioso, Rossella De Angelis, Jacopo Ciaffi, Luana Mancarella, Marcella Visentini, Francesca Motta, Virginia Caira, Alberto Lo Gullo, Caterina Naclerio, Elena Marchetti, Sebastiano Lorusso, Jessica Luppino, Roberta Foti, Massimo Reta

    Published 2023-06-01
    “…Objectives To better define the spectrum of new-onset post-COVID-19 and post-COVID-19 vaccine inflammatory rheumatic diseases (IRD) from a large multicentric observational study.Methods Consecutive cases of IRD encountered during a 12-month period and satisfying one of the following inclusion criteria: (a) onset of the rheumatic manifestations within 4 weeks from SARS-CoV-2 infection or (b) onset of the rheumatic manifestations within 4 weeks from the administration of one of the COVID-19 vaccines ws recruited.Results The final analysis cohort comprised 267 patients, of which 122 (45.2%) in the post-COVID-19 and 145 (54.8%) in the postvaccine cohort. …”
    Get full text
    Article
  20. 1460